Nymox Pharmaceutical Corporation (NYMXF)
USD 0.14
(-8.36%)
USD 0.14
(-8.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 680 Thousand USD | 155.28% |
| 2022 | -1.23 Million USD | -180.18% |
| 2021 | -439 Thousand USD | 86.22% |
| 2020 | -3.18 Million USD | 37.45% |
| 2019 | -5.09 Million USD | 35.92% |
| 2018 | -7.94 Million USD | -833.73% |
| 2017 | -851 Thousand USD | 21.71% |
| 2016 | -1.08 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | -70 Thousand USD | 94.31% |
| 2023 Q4 | 680 Thousand USD | 1146.15% |
| 2023 Q3 | -65 Thousand USD | -109.66% |
| 2023 Q2 | 673 Thousand USD | 383.97% |
| 2023 Q1 | -237 Thousand USD | 80.73% |
| 2022 Q1 | -333 Thousand USD | 24.15% |
| 2022 Q4 | -1.23 Million USD | 50.34% |
| 2022 Q3 | -2.47 Million USD | 34.57% |
| 2022 Q2 | -3.78 Million USD | -1036.94% |
| 2021 Q4 | -439 Thousand USD | 83.72% |
| 2021 Q3 | -2.69 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | 52008.397% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 87.961% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 98.411% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 372.414% |
| Rebus Holdings, Inc. | 305 Thousand USD | -122.951% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 110.786% |
| Qrons Inc. | 351.42 Thousand USD | -93.497% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -9.261% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 98.434% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 3432.027% |
| Skye Bioscience, Inc. | -5.72 Million USD | 111.885% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 95.686% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 83.487% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -69.218% |
| SQZ Biotechnologies Company | -36.23 Million USD | 101.876% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 69.673% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 26.66% |
| Mesoblast Limited | 55.85 Million USD | 98.783% |
| Marizyme, Inc. | 18.56 Million USD | 96.338% |
| Genus plc | 190.6 Million USD | 99.643% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 69.586% |
| Pharming Group N.V. | 109.8 Million USD | 99.381% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 20.952% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 43.982% |
| ContraFect Corporation | -6.02 Million USD | 111.284% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -405.054% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 41.147% |
| IMV Inc. | 7.67 Million USD | 91.135% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 87.641% |
| MultiCell Technologies, Inc. | 90.04 USD | -755119.902% |
| ONE Bio Corp. | 9.04 Million USD | 92.478% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 192.646% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 94.747% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 50.291% |
| Q BioMed Inc. | 4.06 Million USD | 83.251% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 97.774% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 32.521% |
| Biomind Labs Inc. | 711.4 Thousand USD | 4.414% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 98.877% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 65.99% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 94.69% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -89.041% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -386.395% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -3322.761% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 69.119% |
| GB Sciences, Inc. | 1.74 Million USD | 61.083% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 469.992% |
| HST Global, Inc. | 96.79 Thousand USD | -602.53% |
| CSL Limited | 10.52 Billion USD | 99.994% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -229.75% |
| Halberd Corporation | 144.72 Thousand USD | -369.87% |
| Enzolytics Inc. | 981.65 Thousand USD | 30.729% |
| Agentix Corp. | 37.63 Thousand USD | -1707.021% |
| Resverlogix Corp. | 6.45 Million USD | 89.459% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 201.027% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.034% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 101.446% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 90.383% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 74.895% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 107.692% |
| AVAX Technologies, Inc. | -5.9 Million USD | 111.519% |
| Zenith Capital Corp. | 10.06 Thousand USD | -6656.757% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.064% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -239.267% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 71.501% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -313.351% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 3812.196% |
| Kadimastem Ltd | -253.1 Thousand USD | 368.666% |
| Helix BioMedix, Inc. | -2.57 Million USD | 126.459% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 96.646% |
| BioStem Technologies, Inc. | 4.47 Million USD | 84.794% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -237.881% |
| LadRx Corporation | -2.03 Million USD | 133.391% |
| Cell Source, Inc. | 9.23 Million USD | 92.634% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -7.058% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -7.058% |
| NovAccess Global Inc. | 2.17 Million USD | 68.785% |
| Affymax, Inc. | -5.59 Million USD | 112.149% |
| Itoco Inc. | 228.3 Thousand USD | -197.847% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -400.04% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 86.282% |
| Mobile Lads Corp. | 484.23 Thousand USD | -40.429% |
| CytoDyn Inc. | 20.26 Million USD | 96.644% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 105200.464% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 7436.805% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 91.176% |
| SYBLEU INC | 473.71 Thousand USD | -43.547% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 84.743% |
| International Stem Cell Corporation | 2.59 Million USD | 73.745% |
| Bioxytran, Inc. | 1.89 Million USD | 64.19% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -989.517% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 68.82% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 80.198% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 92.05% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 11.986% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 154.4% |
| Neutra Corp. | 52.18 Thousand USD | -1203.006% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 127.32% |
| PureTech Health plc | -167.19 Million USD | 100.407% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 377.655% |
| IXICO plc | -4.44 Million USD | 115.3% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 94.856% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 98.76% |
| CSL Limited | 10.52 Billion USD | 99.994% |
| Cellectis S.A. | -43.81 Million USD | 101.552% |